title: Effect of latanoprost 0.005% and brimonidine 0.2% on intraocular pressure after phacoemulsification and intraocular lens implantation surgery.
authors.forename: Haydar
authors.initials: H
authors.lastname: Erdogan
authors.forename: M Ilker
authors.initials: MI
authors.lastname: Toker
authors.forename: M Kemal
authors.initials: MK
authors.lastname: Arici
authors.forename: Ayşen
authors.initials: A
authors.lastname: Topalkara
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000068438:Brimonidine Tartrate; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D000077338:Latanoprost; D019654:Lens Implantation, Intraocular / Q000379:methods; D008875:Middle Aged; D018918:Phacoemulsification / Q000379:methods; D011182:Postoperative Care; D011183:Postoperative Complications; D011446:Prospective Studies; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage* / Q000009:adverse effects; D011810:Quinoxalines / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; D000077338:Latanoprost